Overview
AVICHINA (2357)
AviChina Industry & Technology Company Limited engages in the development, manufacture, and sale of civil aviation and defense products in Hong Kong and interna...
- Open
- 2.980
- High
- 2.980
- Low
- 2.890
- Prev. Close
- 2.955
- Volume
- 10.41M
- Turnover
- 30.32M
- Avg Price
- 2.913
- Bid/Ask Ratio
- 74.00%
- Amplitude
- 3.05%
- 52wk High
- 4.584
- Volume Ratio
- 0.78
- Turnover Ratio
- 0.17%
- 52wk Low
- 2.775
- HK Mkt Cap
- 17.95B
- Market CapHKD
- 23.04B
- P/ETTM
- 12.85
- P/EDynamic
- 12.16
- P/EStatic
- --
- EPSTTM
- 0.225
- EPSDynamic
- 0.238
- EPSStatic
- --
- BVPS
- 5.08
- P/B
- 0.57
- HK Shares
- 6.21B
- Dividend YieldTTM
- 2.63%
- DividendTTM
- 0.076
- Shares
- 7.97B
- Min lot size
- 1,000
- Currency
- HKD
AVICHINA Analyst Rating
View moreForecast & Rating
Oct 27, 2026- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Oct, 16
AVICHINA climbed 4.28% to HK$3.165, spiking to HK$3.195 in the morning session before fading to HK$3.070-3.165 in the afternoon, as military groups crowded overseas defence exhibitions, AVIC debuting at the 2026 Azerbaijan International Defence Exhibition and the Z-10ME helicopter appearing at Africa Aerospace and Defence, alongside New China Life's purchase of 31m shares at about HK$3.08. Fundamentals ran the other way: Q2 revenue of HK$21.8bn rose 6.38% yoy, while net profit of HK$475m and EPS of HK$0.0595 both fell roughly 15.8%. The stock sits 32% below its 52-week high of HK$4.66 and is down 25.35% YTD, yet has reclaimed the MA20 of 3.028 and MA60 of 2.977, with the consensus target 53.8% above spot. Still, the retreat from HK$3.190 points to limited follow-through.
- Oct, 2
After opening at the session high of HK$3.190, the stock slid to HK$3.070 by 10:01 BJ and recovered to HK$3.115 by midday, a morning range of roughly 3.9% on 3.166 million shares worth about HK$9.85 million. The softness tracks AviChina's first-half 2026 results, where net profit attributable to owners fell 20.1% year on year to RMB 823 million while revenue edged up only 0.93%; the latest quarter showed net profit of HK$475 million, down 15.77%, and operating profit down 6.08%, as mid-year earnings divergence weighed on the aviation segment. Revenue still grew 6.42% with a 2.18% net margin, so scale expanded even as profitability contracted. At a PE of 13.85, PB of 0.610 and market value near HK$24.8 billion, the shares still sit below book value. Even so, weekly recaps show brokers keeping buy or strong buy consensus ratings.
- Sep, 30
Brokers kept buy ratings on AVICHINA last week and the stock has been repairing from its Sept 15 52-week low of HK$2.775, and 2357.HK duly ground higher on Wednesday: it dipped to HK$3.085 early, tagged an intraday HK$3.250 at 10:03 BJ, then settled at HK$3.230, up 4.03% from HK$3.105, on 40.28 million shares and HK$129 million turnover. Revenue and profit are not moving together, though - Q2 2026 operating revenue of HK$21.82 billion rose 6.42% y/y while net profit of HK$475 million and EPS of HK$0.0594 fell 15.77% and 15.79%, operating income slipped 6.08% and H1 net profit attributable dropped 20.1% to RMB 823 million, leaving PE at 14.36x and PB at 0.64x. The price is still 30.69% below its Jan 8 52-week high of HK$4.66 and down 23.82% YTD, yet sits above MA20 of 2.95 and MA60 of 2.955. Aviation and pharma broadly lagged in the mid-2026 reporting season, so flows toward tech remain a variable.
- Sep, 22
AVICHINA rose 1.53% to close at HKD 2.980, staging a reversal after an early dip to HKD 2.920, then steadily climbing to an intraday high of HKD 2.985 in late afternoon. Citi maintained a Buy rating and trimmed its target price to HKD 4, but the day's momentum was mainly driven by a technical rebound from the stock's 52-week low of HKD 2.775 set the prior week. The company's H1 net profit dropped over 15% y/y, yet revenue posted a modest ~6.4% increase, leaving the stock trading at 13.25x P/E and 0.59x P/B. With a YTD decline of nearly 30% and the price still below both the 20-day MA (HKD 2.914) and 60-day MA (HKD 2.945), valuation repair has yet to reflect the incremental improvement in fundamentals, though the medium-term downtrend remains intact with overhead MA60 resistance.
- Sep, 21
AVICHINA rallied in the afternoon session, closing up 3.37% at HKD 2.915, reclaiming its MA20 (2.91) while still 37.45% below the 52-week high of 4.66 and down 31.25% YTD. The rise was primarily driven by Citi's maintained Buy rating with a target cut from HKD 3.5 to HKD 4, alongside broad market rotation toward AI and manufacturing themes. Despite Q2 EPS of HKD 0.0594 falling 15.81% YoY and net profit dropping 15.79%, first-half revenue edged up 0.93% to RMB 37.8 billion, indicating operational resilience. The stock trades at just 0.57x book value, though earnings contraction continues to weigh on valuation.
News
Weekly Review · Weekly Recap | AVICHINA +4.97%, most brokers rate it buy
Global Report · Tungsten Is Up Almost 50%. China Gas Just Cut Its Dividend.
Global Report · China Ruyi Has an AI Story Now. Every Hong Kong Small Cap Does.
Weekly Review · Weekly Recap | AVICHINA -4.74%, consensus target above spot
Global Report · Hong Kong's forgotten small caps ride insurance stakes, FDA wins and buybacks
Global Report · Hong Kong's Niche Stocks Chart Divergent Paths: Transsion's IPO Bounce, Mixue's Mongolia Push, CALB's Funding Sprint
